The Valley Desk

NCT00785226 · Interventional trial

RDEA119 and Sorafenib Combination Dose Escalation Study

Overall registry status Completed

Phase 1 · Phase 2

Conditions Advanced Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov